Methylenetetrahydrofolate reductase gene polymorphisms and neural tube defects epidemiology in the Slovak population

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 88, Issue 8, 2010, Pages 695-700

  Behunova, Jana ^a   Klimcakova, Lucia ^a   Zavadilikova, Eva ^a   Potocekova, Dana ^a   Sykora, Pavol ^b   Podracka, Ludmila ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b Physics and Informatics   (Slovakia)

Author keywords

A1298C; C677T; Epidemiology; MTHFR; Neural tube defects; Roma; Slovak population

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NEURAL TUBE DEFECT; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SLOVAKIA;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEURAL TUBE DEFECTS; POLYMORPHISM, GENETIC; PREVALENCE; SLOVAKIA; YOUNG ADULT;

EID: 77955687319     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20692     Document Type: Article

References (42)

1. Afman LA, Blom HJ, Drittij MJ, et al. 2005. Inhibition of transmethylation disturbs neurulation in chick embryos. Brain Res Dev Brain Res 158:59-65.
2. Amorim MR, Lima MAC, Castilla EE, Orioli IM. 2007. Non-Latin European descent could be a requirement for association of NTDs and MTHFR variant 677C>T: a meta-analysis. Am J Med Genet A 143A:1726-1732.
3. Beaudin AE, Stover PJ. 2007. Folate-mediated one-carbon metabolism and neural tube defects: balancing genome synthesis and gene expression. Birth Defects Res C Embryo Today 81:183-203.
4. Beaudin AE, Stover PJ. 2009. Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview. Birth Defects Res A Clin Mol Teratol 85:274-284.
5. Behunová J, Podracká L. 2008. Neural tube defects: current opinion on etiopathogenesis and prevention potential of folic acid. Czecho-Slovak Pediatr 63:38-46. [In Slovak]
6. Berry RJ, Li Z, Erickson JD, et al. 1999. Prevention of neural-tube defects with folic acid in China. New Engl J Med 341:1485-1490.
7. Blom HJ. 2009. Folic acid, methylation and neural tube closure in humans. Birth Defects Res A Clin Mol Teratol 85:295-302.
8. Blom HJ, Shaw GM, den Heijer M, et al. 2006. Neural tube defects and folate: case far from closed. Nat Rev Neurosci 7:724-731.
9. Botto LD, Yang Q. 2000. 5,10-methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862-877.
10. Boyles AL, Hammock P, Speer MC, et al. 2005. Candidate gene analysis in human neural tube defects. Am J Med Genet C Semin Med Genet 135C:9-23.
11. Csaky-Szunyogh M, Horvath-Puho E, Vamos M, et al. 2008. Role of the Hungarian congenital abnormality registry in prevention of birth defects. Abstract Book, 1st Central and Eastern European Summit on Preconception Health and Prevention of Birth Defects, Budapest, Hungary, August 27, 2008. p. 30.
12. Czeizel AE, Dudás I. 1992. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. New Engl J Med 24 327:1832-1835.
13. Czeizel AE, Révész C. 1970. Major malformations of the central nervous system in Hungary. Br J Prev Soc Med 24:205-222.
14. Czeizel AE, Tímár L, Botto L. 2001. A metilé netetrahydrofolát reduktáz gén polimorfizmusának (C677T) magyarországi gyakorisága. Orvosi Hetilap 142:1227-1229.
15. De Marco P, Calevo MG, Moroni A, et al. 2002. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 47:319-324.
16. Dunlevy LPE, Burren KA, Mills K, et al. 2006. Integrity of the methylation cycle is essential for mammalian neural tube closure. Birth Defects Res A Clin Mol Teratol 76:544-552.
17. Félix TM, Leistner S, Giugliani R. 2004. Metabolic effects and the methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with neural tube defects in southern Brazil. Birth Defects Res A Clin Mol Teratol 70:459-463.
18. Frosst P, Blom HJ, Milos R, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
19. Gonzalez-Herrera L, Castillo-Zapata I, Garcia-Escalante G, et al. 2007. A1298C polymorphism of the MTHFR gene and neural tube defects in the state of Yucatan, Mexico. Birth Defects Res A Clin Mol Teratol 79:622-626.
20. Gos M, Eliwerska E, Szpecht-Potocka A. 2004. Mutation incidence in folate metabolism genes and regulatory genes in Polish families with neural tube defects. J Appl Genet 45363-368.
21. Greene NDE, Copp AJ. 2009. Development of the vertebrate central nervous system: formation of the neural tube. Prenat Diagn 29:303-311.
22. Greene NDE, Stanier P, Copp AJ. 2009. Genetics of human neural tube defects. Hum Mol Genet 18:R113-R129.
23. Gresham D, Morar B, Underhill PA, et al. 2001. Origins and divergence of the Roma (Gypsies). Am J Hum Genet 69:1314-1331.
24. Institute of Health Information and Statistics of the Slovak Republic. 1996-2004. Health annual of Slovak Republic 1996-2004. Bratislava: Government of Slovakia.
25. Institute of Health Information and Statistics of the Czech Republic. 2007. Czech health statistic yearbook 2007. Available at: http://www.uzis.cz/ download.php?ctg=10&search-name=ročenk®ion=100&mnu-id= 5300&lng5cz. Accessed 03/18/2010.
26. Isotalo PA, Wells GA, Donnelly JG, et al. 2000. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 67:986-990.
27. Johanning GL, Wenstrom KD, Tamura T, et al. 2002. Changes in frequencies of heterozygous thermolabile 5,10-methylenetetrahydrofolate reductase gene in fetuses with neural tube defects. J Med Genet 39:366-367.
28. Krajčovičová-Kudláčková M, Blažíček P, Ginter E, Valachičová M. 2004. Homocysteine and its nutritional determinants in two ethnic groups of Slovakia. Cent Eur J Publ Health 12:217-219.
29. Martsenyuk OP, Mislanova C, Romanets KL, et al. 2009. The level of low molecular thiols and folate in human. Ukr Biochem J 81:94-104. [In Ukrainian]
30. Molloy AM, Brody LC, Mills JL, et al. 2009. The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects. Birth Defects Res A Clin Mol Teratol 85:285-294.
31. MRC Vitamin Study Research Group (Wald N, Sneddon J, Densem J, Frost C, Stone R). 1991. Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 338:131-137.
32. Ogino S, Wilson RB. 2003. Genotype and haplotype distributions of MTHFR 677C>T and 1298A>C single nucleotide polymorphisms: a meta-analysis. J Hum Genet 48:1-7.
33. Parle-McDermott A, Mills JL, Kirke PN, et al. 2003. Analysis of the MTHFR 1298A->C and 677C->T polymorphisms as risk factors for neural tube defects. J Hum Genet 48:190-193.
34. Perez AB, D'Almeida V, Vergani N, et al. 2003. Methylenetetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. Am J Med Genet A 119A:20-25.
35. Pietrzyk JJ, Bik-Multanowski M, Sanak M, et al. 2003. Polymorphisms of the 5,10-methylenetetrahydrofolate and the methionine synthase reductase genes as independent risk factors for spina bifida. J Appl Genet 44:111-113.
36. Relton CL, Wilding CS, Pearce MS, et al. 2004. Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 41:256-260.
37. Smithells RW, Seller MJ, Harris R, et al. 1983. Further experience of vitamin supplementation for prevention of neural tube defects recurrences. Lancet 1:1027-1031.
38. Stegmann K, Ziegler A, Ngo ETKM, et al. 1999. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD). Am J Med Genet 87:23-29.
39. Van der Linden IJ, Heil SG, van Egmont Petersen M, et al. 2008. Inhibition of methylation and changes in gene expression in relation to neural tube defects. Birth Defects Res A Clin Mol Teratol 82:676-683.
40. Van der Put NMJ, GabreQls F, Stevens EMB, et al. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects? Am J Hum Genet 62:1044-1051.
41. Veselá K, Pavlíková M, Janoší ková B, et al. 2005. Genetic determinants of folate status in central Bohemia. Physiol Res 54:295-303.
42. Wilcken B, Bamforth F, Li Z, et al. 2003. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas worldwide. J Med Genet 40:619-625.